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PRECLINICAL STUDIES
acrophage Colony-Stimulating Factor
reatment After Myocardial Infarction Attenuates
eft Ventricular Dysfunction by Accelerating Infarct Repair
oshiyuki Yano, MD,* Tetsuji Miura, MD, PHD, FACC,* Peter Whittaker, PHD,†
akayuki Miki, MD, PHD,* Jun Sakamoto, MD, PHD,* Yuichi Nakamura, MD,*
oshihiko Ichikawa, MD, PHD,* Yoshihiro Ikeda, MD,* Hironori Kobayashi, MD,*
atsuhiko Ohori, MD,* Kazuaki Shimamoto, MD, PHD*
apporo, Japan; and Worcester, Massachusetts
OBJECTIVES We aimed to determine the effects of macrophage colony-stimulating factor (M-CSF) and
granulocyte colony-stimulating factor (G-CSF) treatment on both the repair process and
ventricular function after myocardial infarction (MI).
BACKGROUND The M-CSF and G-CSF have multiple potential effects on cells involved in wound repair.
METHODS Myocardial infarction was induced by 45- or 90-min coronary occlusion and reperfusion in
rats with or without subsequent injection of M-CSF (106 IU/kg/day) or G-CSF (50
g/kg/day) for five days. We examined histology and messenger ribonucleic acid (mRNA),
and assessed left ventricular function in situ using a conductance catheter.
RESULTS Five days after MI, M-CSF increased the number of ED-1–positive cells, mRNA levels of
transforming growth factor--1, collagen I and III, and collagen fibers within the infarct.
Fourteen days after MI, induced by 45-min ischemia, left ventricular end-systolic elastance
(Ees) was reduced (1,191 87 mm Hg/ml vs. 1,812 150 mm Hg/ml) and both isovolumic
relaxation time constant () (11.9 0.9 ms vs. 8.5 0.4 ms) and left ventricular end-diastolic
volume (LVEDV) (0.225  0.014 ml vs. 0.172  0.011 ml) increased versus sham-operated
rats. These alterations after MI were attenuated by M-CSF (Ees  1,650  146,   9.7 
0.7, LVEDV  0.199  0.012) but not by G-CSF. This beneficial effect of M-CSF on Ees
was also detected in hearts with MI induced by 90-min ischemia. Furthermore, M-CSF
increased collagen content within infarcts and reduced the proportion of thin collagen fibers
14 days after MI. The Ees significantly correlated with infarct collagen content. Nevertheless,
neither M-CSF nor G-CSF modified infarct size.
CONCLUSIONS The M-CSF treatment attenuates deterioration of left ventricular function after MI by
accelerating infarct repair. (J Am Coll Cardiol 2006;47:626–34) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.037College of Cardiology Foundation
u
o
r
i
r
r
l
a
m
M
T
S
S
D
a
(
l
Nyocardial salvage by reperfusion of ischemic tissue is the
rimary strategy to prevent heart failure after acute myocar-
ial infarction (MI). Nonetheless, recent studies (1–3)
emonstrate that modification of the infarct’s repair process
lso profoundly influences subsequent ventricular function.
ne possible manipulation of infarct repair is to mobilize
nflammatory cells and bone marrow stem cells by cytokine
dministration. In fact, granulocyte colony-stimulating fac-
or (G-CSF) administration has been reported to enhance
yocyte regeneration and angiogenesis in peri-infarct re-
ions (2–4) and to increase collagen deposition in infarcted
reas (3). We also showed that a combination of G-CSF
nd macrophage colony-stimulating factor (M-CSF) atten-
ated remodeling of the border zone of infarcted hearts (5).
evertheless, these earlier studies (2–5), except for one
From the *Second Department of Internal Medicine, Sapporo Medical University
chool of Medicine, Sapporo, Japan; and the †Departments of Emergency Medicine
nd Anesthesiology, University of Massachusetts Medical School, Worcester,
assachusetts. Supported by grants #08670812 and #14770322 from Japan Society
or the Promotion of Science and Hokkaido Heart Association Grant for Research.l
Manuscript received July 1, 2005; revised manuscript received August 29, 2005,
ccepted September 8, 2005.sing rabbits (1), employed permanent coronary artery
cclusion to induce MI, and hence the effects of G-CSF on
eperfused infarcts remain poorly characterized and the
nfluence of M-CSF alone has not been examined.
Thus, because the majority of acute MI patients receive
eperfusion therapy, we employed a rat model of ischemia-
eperfusion to evaluate the effects of G-CSF and M-CSF on
eft ventricular (LV) pressure-volume relationships in situ
nd their association with structural changes within the
yocardium.
ETHODS
he study was approved by the Animal Use Committee of
apporo Medical University.
urgical preparation and study groups. Male Sprague-
awley rats (8 to 10 weeks old; 280 to 380 g) were
nesthetized with an intraperitoneal injection of ketamine
90 mg/kg) and xylazine (10 mg/kg), intubated, and venti-
ated (Harvard Apparatus respirator, model 683; South
atick, Massachusetts) with supplemented oxygen. After a
eft thoracotomy, a snare was placed around the left coro-
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peration or 45 min of coronary occlusion followed by
eperfusion and all rats received antibiotics after surgery (10
g ampicillin and 10 mg cloxacillin, intramuscularly).
wenty percent of the MI rats died within the first 24 h
fter the operation (none died thereafter), and surviving rats
ere randomized to MI, MIM-CSF, and MIG-CSF
roups 24 h after surgery. In the MI, MI  M-CSF, and
IG-CSF groups, rats received intraperitoneal injection
f saline, human recombinant M-CSF (106 IU/kg/day) and
-CSF (50 g/kg/day), respectively, from day 1 to day 5
fter MI. Macrophage colony-stimulating factor and
-CSF were provided by Kyowa Hakko Kogyo Co. (To-
yo, Japan) and Chugai Pharmaceutical Co. (Tokyo, Japan),
espectively. These dosing protocols were selected on the
asis of our previous study (5), which revealed the ability of
ombined M-CSF and G-CSF treatment to attenuate
order zone remodeling in a permanent occlusion model.
lood samples were collected 5 days after MI, and analysis
igure 1. Infarct histology five days after infarction (hematoxylin-eosin
acrophage colony-stimulating factor (M-CSF); (C) MI  granulocyte
Abbreviations and Acronyms
ANOVA  analysis of variance
Ees  left ventricular end-systolic elastance
ESPVR  end-systolic pressure volume relation
GAPDH  glyceraldehydes 3-phosphate dehydrogenase
G-CSF  granulocyte colony-stimulating factor
HE  hematoxylin and eosin
LVEDP  left ventricular end-diastolic pressure
LVEDV  left ventricular end-diastolic volume
M-CSF  macrophage colony-stimulating factor
MI  myocardial infarction
mRNA  messenger ribonucleic acid
PSR  picrosirius red
TGF  transforming growth factorecrosis. (D) Numbers of ED1-positive cells in central infarct and non-infarct
0.05 vs. control MI group.f cardiac function was performed 14 days after MI. Hearts
ere excised under anesthesia for histological or messenger
ibonucleic acid (mRNA) analyses 5 or 14 days after MI. In
he second protocol, rats were assigned to sham operation or
0-min coronary occlusion and reperfusion. Surviving rats
ere randomized to either the MI or MIM-CSF groups;
-CSF was administered as in the first protocol, and LV
unction was assessed 14 days later.
istological analysis of inflammation and regenerating
ells: five days after MI. Pilot experiments revealed that
he number of Ki-67–positive cells peaked between three
nd five days after MI; hence the presence of regenerating
ells was investigated five days after MI. Excised hearts were
mmersion fixed in 10% buffered formalin, and four cross-
ectional, 2-mm-thick slices were cut. Histology slides were
repared from each slice. We measured infarct area and the
entral core of necrosis (Fig. 1) in hematoxylin and eosin
HE)-stained sections using Scion Image (Scion Co., Fred-
rick, Maryland) and summed the area data from each slide
or each heart. The number of neutrophils within infarct
egions was counted in 10 fields (each 250 250 m;400
agnification), and the data were averaged for each heart.
he sections were also incubated with antibodies against
onocyte/macrophage (ED-1, DAKO, Glostrup, Den-
ark), osteopontin (OPN, IBL, Takasaki, Japan), Ki-67
DAKO), a marker of cell proliferation, and -sarcomeric
ctin (Zymed, South San Francisco, California). Immuno-
taining was performed using a peroxidase-based technique
ith a DAKO EnVision kit and detected using diamino-
enzidine (DAKO). ED1- and OPN-positive cells were
ounted in 10 fields (250  250 m; 400 magnification)
andomly selected from the central infarct region and from
on-infarcted tissue. We also examined sections (four per
ing, 40 magnification). (A) Myocardial infarction (MI); (B) MI 
-stimulating factor (G-CSF). G  granulation tissue; N  coagulationstain
colonyregions. Inset shows representative staining with anti-ED-1 antibody. *p
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arcomeric actin antibodies, fluorescein isothiocyanate-
onjugated secondary antibodies and tetramethylrhodamine
sothiocyanate-conjugated secondary antibodies (used for de-
ection of Ki-67 and -sarcomeric actin, respectively) with
confocal laser microscope.
ransforming growth factor (TGF)--1 and collagen
ene expression: five days after MI. Levels of TGF--1,
ollagen I, collagen III, and glyceraldehydes phosphate
ehydrogenase (GAPDH) mRNAs in infarcted and non-
nfarcted regions were determined as previously described
5). The level of GAPDH mRNA was used to normalize
evels of the other target gene mRNAs.
istological analysis of fibrosis and capillary density: 14
ays after MI. After measurement of ventricular function
4 days after MI (see the following text), hearts were fixed
nd sectioned as described for the 5-day samples. We
easured infarct area and LV cross-sectional area in HE-
tained sections and expressed infarct size as a percentage of
V area. To calculate infarct transmurality, total LV wall
hickness and infarct thickness were measured at the center
nd both lateral border zones in each slide, and the ratio of
nfarct thickness to total wall thickness in all slides was
veraged for each heart.
Using sections stained with picrosirius red (PSR), areas
ccupied by collagen (stained red) in infarcted and non-
nfarcted regions were determined (40 magnification)
sing brightfield illumination. Images were converted to
ed, green, blue format by PhotoShop (Adobe Systems Inc.,
an Jose, California), and areas positive for collagen staining
n both regions were determined after conversion to binary
mages (Scion Image). The total area of infarcted and
on-infarcted regions was also determined to normalize the
ollagen content measurements. We assessed, in six rats per
roup, three additional structural parameters in PSR-
tained sections viewed with circularly polarized light: col-
agen fiber color, the retardation of light by collagen, and
wo-dimensional fiber orientation. As thickness increases,
ber color changes from green to yellow to orange to red;
he relative distribution of these different colors was mea-
ured in three regions (one from the scar’s center and one
rom each lateral edge; each 0.05 mm2) using image-
nalysis software (SigmaScan Pro 5.0, Chicago, Illinois) and
reviously published methodology (6). The retardation ()
f polarized light is given by the equation   t (ne  no),
here t is sample thickness and the term in parentheses is
he difference in refractive index between the directions
arallel and perpendicular to the fiber (7). The latter
epends on collagen’s molecular anisotropy, which increases
uring maturation. Retardation, which has also been shown
o increase progressively in scars (8), was measured using an
utomated analysis system (PolScope, CRI Inc., Woburn,
assachusetts); 50 measurements (locations selected by
onstruction of a 10  5 point grid over each image) were
aken in each of the three regions and averaged. Fiber
rientation was also assessed with the PolScope system and r0 measurements recorded at the same locations as the
etardation measurements. The degree of fiber alignment
as represented by calculation of the angular deviation of
ach orientation distribution; the smaller the angular devi-
tion, the more aligned the fibers (7). The accuracy of the
utomated methods has been validated for both of these
arameters (P. Whittaker, unpublished data, 2004).
To determine capillary density, we employed immuno-
taining with an antibody against Factor VIII (DAKO), an
ndothelial marker. The number of factor VIII-positive
essels was counted in 10 randomly selected fields (250 
50 m; 400 magnification) in each slide, and the data
ere averaged for each heart.
n situ ventricular function 14 days after MI. We as-
essed in situ LV function using a miniature conductance
atheter as previously described (9). Rats, anesthetized with
entobarbital sodium (80 mg/kg), were ventilated with
xygen-supplemented room air. A PE-50 catheter was
laced in the right carotid artery to monitor pressure. The
hest was opened via a midline sternotomy, a conductance
atheter with a 2-mm interelectrode distance (Unique Med-
cal, Tokyo, Japan) was inserted into the LV cavity through
he apex, and the distal driving electrode and proximal
lectrode were positioned at the level of the aortic valve and
ear the apex, respectively. A 3-F catheter-tip microma-
ometer (Miller Instruments, Houston, Texas) was inserted
nto the LV through the apex. To obtain LV pressure-
olume loops, we used a string-occluder to gradually occlude
he ascending aorta until left ventricular end-diastolic vol-
me (LVEDV) slightly increased. The respirator was
topped during data acquisition to avoid respiratory-
ediated hemodynamic fluctuation. For measurement of a
arallel conductance volume, 0.02 ml of 5% NaCl solution
as injected into the pulmonary artery, which transiently
hanged LV blood conductivity. The LV conductance
olume was calculated by subtraction of the parallel conduc-
ance volume from the actual measured volume. Finally,
lood sample conductivity was measured using a small
uvette. Since hypotension (50 mm Hg) may cause
yocardial hypoperfusion, rats that failed to maintain dia-
tolic pressure above this level were excluded. Integral 3
Unique Medical, Tokyo, Japan) was used to store data from
he conductance catheter and tip-manometer and to calcu-
ate the systolic and diastolic functional parameters, includ-
ng left ventricular end-systolic elastance (Ees). Left ven-
ricular end-systolic elastance was determined from the
lope of the LV end-systolic pressure-volume relationships.
tatistics. All data are presented as means  SEM. Inter-
roup differences were examined by one-way analysis of
ariance (ANOVA), and when the p value for the overall
ifference was0.05, pairwise comparisons were performed
y Student-Newman-Keuls post hoc test. The p values
resented in the Results are those obtained for pairwise
omparisons unless otherwise stated. Differences between
egression lines were tested by analysis of covariance.
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lood counts. The number of peripheral leukocytes was
ignificantly higher in the MI group than in the sham group
9,443  535/mm3 vs. 6,167  921/mm3). A further
ncrease was observed in the MI  G-CSF group (19,300
2,981/mm3, p  0.05 vs. the MI group), but not in the
I  M-CSF group (10,962  1,046/mm3). The
umber of red blood cells and platelets were similar in all
tudy groups (data not shown).
istological analysis five days after MI. Five days after
nfarction in the control hearts, the peripheral zone of
ecrotic myocytes had been absorbed and replaced by
ranulation tissue (Fig. 1A). Collagen content in the infarct
as increased from 11.0 1.7% to 17.6 1.7% by M-CSF
p  0.05), but not by G-CSF (12.2  2.3%). Macrophage
olony-stimulating factor increased the number of ED1-
ositive cells in infarct regions, whereas no significant effect
as detected in non-infarct regions (Fig. 1D). OPN-
ositive macrophages were concentrated around the central
ore of necrotic myocytes, but were only sporadically present
n granulation tissue. These infarct-region OPN-positive
ells tended to be increased by M-CSF (100 9/mm2), but
ot by G-CSF (70  13/mm2) versus MI controls (77 
/mm2); however, the difference was not significant (p 
.124 for overall ANOVA). The coagulative core necrosis
olume did not differ between groups; MI, 13.8  4.2%;
I  M-CSF, 9.0  2.4%; MI  G-CSF, 16.1  3.6%;
 0.386 for overall ANOVA. Despite significant differ-
igure 2. Ki-67–positive cells in infarcts and border zones five days after M
nd the infarct–non-infarct border zone (A). At higher magnification, Ki-
B, thick arrow), spindle-shaped fibroblasts (B, thin arrow) and endothelial cel
uorescence) and anti–-sarcomeric actin (red fluorescence).nces in peripheral neutrophil count, the numbers of neu-
rophils within the infarcts were similar: MI, 142  18;
I  M-CSF, 123  17; MI  G-CSF, 153  23/mm2.
he Ki-67–positive cells found around necrotic myocytes
nd in the granulation tissue appeared to be macrophages,
ndothelial cells, and spindle-shaped fibroblasts (Fig. 2A to
C). In addition, a few Ki-67–positive cells were co-labeled
ith anti--sarcomeric actin in the MI  G-CSF group
Fig. 2D), but not in the MI and MI  M-CSF groups.
GF--1 and collagen mRNA expression five days after
I. The mRNA levels of TGF--1 and collagen I and III
ere significantly elevated in the infarct (Fig. 3). The
GF--1 and collagen III expression in the non-infarct
egion were similar to the levels in sham-operated hearts.
acrophage colony-stimulating factor enhanced elevation
f mRNA levels of TGF--1 and collagen I and III in the
nfarct, but not in non-infarcted tissue. Granulocyte colony-
timulating factor did not significantly increase TGF--1,
ollagen I, or collagen III expression levels in infarct areas.
istological analysis 14 days after MI. Because of a
echnical error, one MI control-group heart was improperly
xed and was not included in the histological analysis.
ourteen days after MI, heart mass and heart-to-body mass
atio were significantly larger in the MI group than in the
hams, indicating MI-associated ventricular remodeling
Table 1). Most of the infarcted area was composed of
ranulation and fibrous tissue (Figs. 4A to 4C), while
yocytes in non-infarcted regions appeared hypertrophic.
ells with Ki-67–positive nuclei were mainly observed in granulation tissue
sitive cells were shown to be mononuclear cells, specifically macrophagesI. C
67–pols (C, thin arrow). (D) A cell co-stained with anti-Ki-67 antibody (green
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nfarct size, infarct transmurality, or numbers of Factor
III-positive vessels in infarcted and non-infarcted regions.
acrophage colony-stimulating factor significantly in-
reased collagen, which had replaced granulation tissue, in
he infarct region without any effect on collagen level in the
on-infarcted areas. We found an inverse correlation be-
ween infarct size and infarct collagen content in the MI
roup (Fig. 5), consistent with our earlier finding that the
ate of infarct repair depends upon infarct size (10). The
egression line for the MI  M-CSF group was shifted
pward versus the MI group, consistent with M-CSF-
ccelerated collagen deposition (Fig. 5). Granulocyte
olony-stimulating factor had no significant effect on colla-
en content in infarcted and non-infarcted areas or on the
nfarct size-collagen content relationship.
Myocardial infarction group scars contained a higher
roportion of thin, green fibers than was found with
igure 3. Effects of M-CSF and G-CSF on TGF--1, collagen I and colla
ene was normalized by GAPDH mRNA level. *p  0.05 vs. Sham, #p
Table 1. Heart Weight and Histological Data
Group
Sham
(n  11)
Heart weight (g) 1.08  0.03
Body weight 402  8
Heart weight/body weight (mg/g) 2.73  0.06
Infarct size/LV (%) —
Transmurality of infarct (%) —
Collagen (%)
Infarct area —
Non-infarct area 3.2  0.2
Factor VIII-positive vessels (/mm2)
Infarct area —
Non-infarct area —
Values are means  SE. *p  0.05 vs. sham. †p  0.05 vs.
Collagen in infarct area (%)  infarct area occupied by collag
% of area occupied by collagen in non-infarct area remote from in
LV  left ventricle; MI  myocardial infarction.-CSF (23.3  2.4% vs. 13.4  3.6%, p  0.05).
onversely, although the proportion of thick, orange fibers
as higher with M-CSF, the difference was not significant
29.5  6.5% vs. 21.5  4.9% MI group). There were no
tatistical differences in fiber color between the MI 
-CSF and MI groups. Collagen retardation was higher
ith M-CSF treatment (61.5  4.9 nm) than in MI
ontrols (45.1  3.5 nm; p  0.05). This 30% increase is
llustrated in the pseudo-color images of representative
egions shown in Figure 6; higher values are denoted by
ellow, orange, and red, while lower values are indicated by
reen and blue. In contrast, G-CSF treatment did not
ncrease retardation versus MI control (51.6  3.2 nm; p 
S). There was no significant inter-group difference in
ngular deviation, indicating no differences in fiber orien-
ation (data not shown).
entricular function 14 days after MI. Table 2 shows the
esults of the 45-min occlusion protocol. Heart rate and LV
I mRNA expression in infarct and non-infarct regions. Expression of each
5 vs. MI. Abbreviations as in Figure 1.
ays After MI
MI
(n  10)
MI  M-CSF
(n  10)
MI  G-CSF
(n  12)
.57  0.07* 1.52  0.04* 1.52  0.05*
410  8 392  7 388  8
.84  0.16* 3.88  0.12* 3.92  0.12*
9.3  3.1 27.5  2.9 28.9  1.6
0.5  2.7 81.8  1.9 82.7  2.2
2.4  2.4 61.9  3.3† 48.8  2.8
5.0  0.4* 4.0  0.4 4.3  0.5
2.4  6.3 152.9  8.7 170.3  8.2
9.2  22.0 227.9  16.8 257.2  15.9
nfarct size/LV (%)  infarct size as % of the left ventricle.
% of whole infarct area. Collagen in non-infarct area (%) 14 D
1
3
2
8
5
16
25
MI. I
en asfarct.
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February 7, 2006:626–34 Effects of M-CSF on Post-Infarct Cardiac Functionnd-systolic and end-diastolic pressures did not differ be-
ween groups. The volume axis intercept of end-systolic
ressure volume relation (V0) and LVEDV in the MI group
ere larger than in the sham group. Although this increase
n V0 was not attenuated by M-CSF or by G-CSF, M-CSF
ignificantly reduced the increase in LVEDV after MI.
urthermore, reduction of Ees after MI was significantly
ttenuated by M-CSF, an effect not seen with G-CSF
Table 2). Left ventricular end-systolic elastance was posi-
ively correlated with infarct collagen content (Fig. 7A) and
egatively correlated with infarct transmurality (Fig. 7B).
eft ventricular end-systolic elastance tended to negatively
orrelate with infarct size (y16.1x 1832, r0.29),
ut did not achieve statistical significance. Tau (), isovolu-
igure 4. Scar collagen deposition 14 days after MI. (A), (D) MI; (B), (E
llumination and (D to F) polarized light. Abbreviations as in Figure 1.
igure 5. Relationship between infarct size and collagen content. In the
I group, infarct collagen content (as percentage of infarct area) correlated
nversely with infarct size (as percentage of the left ventricle [LV]): y 
0.65x  73.26, r  0.82, p  0.05 (open circles). M-CSF treatment
hifted the regression line upwards: y  0.17x  57.24 (closed circles),f
 0.05 vs. the MI group regression line by analysis of co-variance. Other
bbreviations as in Figure 1.ic relaxation time constant, significantly increased after
I; however, this change was blunted by M-CSF
reatment.
Table 3 shows the results of the 90-min occlusion
rotocol. In these experiments, infarcts were almost all
ransmural and were considerably larger than in the 45-min
rotocol. Macrophage colony-stimulating factor attenuated
oth the elevation of LVEDV and the fall in Ees after MI,
lthough the beneficial effect on  was not detected. In
dditional experiments, we confirmed that M-CSF treat-
ent did not affect Ees in normal hearts; Ees and  were
imilar in sham-operated rats with and without M-CSF
1,791 305 vs. 1,931 332 mm Hg/ml, 9.3 0.9 vs. 9.5
0.8 ms, n  4 each group).
ISCUSSION
ffects of M-CSF on ventricular function after MI. We
ound that M-CSF treatment attenuated the usual deteriora-
ion of left ventricular function that occurs after MI. Further-
ore, this benefit was associated with an acceleration of infarct
ealing; specifically, increased scar collagen content and in-
reased collagen fiber thickness within the scar. Nevertheless,
-CSF failed to reduce infarct transmurality; that is, we found
o appreciable muscle regeneration.
In this rat model of ischemia-reperfusion, cardiac output
nd LVEDP were unchanged in infarcted controls, but
VEDV increased and both Ees, a load-insensitive index of
V contractility, and LV dP/dtmax were substantially
educed versus non-infarcted shams (Tables 2 and 3). These
eatures indicate that our ischemia-reperfusion preparation
s a model of compensated LV dysfunction. In our study,
-CSF mitigated deterioration of Ees, a parameter deter-
ined by contractility of non-infarcted muscle, infarct
ransmurality, and collagen content (Fig. 7), presumably via
he observed increase in the latter. A plausible explanation
 M-CSF; (C), (F) MI  G-CSF. PSR staining: (A to C) Brightfieldor the correlation between Ees and infarct collagen content
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Effects of M-CSF on Post-Infarct Cardiac Function February 7, 2006:626–34s that stiffening of the infarcted region by the fibrotic
eplacement of necrotic muscle increases the Ees of the
ntire heart (the sum of elastances in infarcted and non-
nfarcted regions). This explanation is consistent with ear-
ier findings that application of stiff polyester meshes on the
nfarct during the acute phase of infarction improved
entricular function (11,12). The enhanced stiffness of the
nfarcted region also explains the smaller  after MI in the
-CSF–treated versus untreated rats. Although we cannot
ompletely exclude the contribution of factors besides in-
reased collagen content to explain the beneficial effect, a
irect M-CSF–mediated effect on viable myocytes appears
nlikely because M-CSF did not affect LVESE or  in
ham-operated animals.
The association of increased collagen deposition within
he infarct with improved ventricular function (Fig. 7)
ppears to contradict reported beneficial effects of collagen
uppression after MI. Angiotensin-converting enzyme in-
ibitors and matrix metalloprotease inhibitors suppress both
ost-infarct ventricular dysfunction and collagen deposition
13,14). Nevertheless, it is likely that cardiac fibrosis leads to
ifferent outcomes determined not only by its extent, but
lso by its location (infarcted vs. viable regions) and timing
acute vs. chronic phase after infarction). A GM-CSF
igure 6. Representative pseudo-color images illustrating intergroup optica
olor; purple, blue, green, yellow, orange, red. (A) MI, (B) MI  M-C
-CSF–treated scar contains more collagen fibers with high retardation v
Panel width  260 m.) Abbreviations as in Figure 1.
Table 2. Summary of Results From Ventricula
Group
Sham
(n  11)
Vp (ml) 0.172  0.010 0
HR (beats/min) 427  8
LVESP (mm Hg) 88.7  4.7
LVEDP (mm Hg) 3.2  0.6
LVESV (ml) 0.090  0.010 0
LVESV/BW (l/g) 0.205  0.024 0
LVEDV (ml) 0.172  0.011 0
LVEDV/BW (l/g) 0.419  0.030 0
LVEF (%) 48.6  3.6
Cardiac output (ml/min) 35.0  2.8
LVdP/dt max (mm Hg/s) 5519  421
Ees (mm Hg/ml) 1812  150
 (ms) 8.5  0.4
V0 (ml) 0.037  0.007 0
Values are means  SE. *p  0.05 vs. sham. #p  0.05 vs.
BW  body weight; Ees  end-systolic elastance of LV;
of LV pressure; LVEDP  LV end-diastolic pressure; LVE
LVESP  LV end-systolic pressure; LVESV  LV end-sys
V0  volume axis intercept of ESPVR (end-systolic pressure-volu
abbreviations as in Table 1.nducer, romurtide, suppressed collagen deposition in the
nfarcted region during the early phase of MI, resulting in
xpansion of the infarcted zone (15). Suppression of fibrosis
fter infarction by neutralization of interleukin-1 (16) or
y osteopontin gene knockout (17) actually augmented
entricular remodeling and contractile dysfunction. These
ndings suggest that timely increases in scar collagen
eposition can be beneficial for ventricular function.
ffects of M-CSF on infarct repair. Macrophage colony-
timulating factor increased collagen deposition within the
nfarct; particularly in large infarcts (Fig. 5), which is
otentially advantageous because large infarcts heal more
lowly than small infarcts (10). Furthermore, although fiber
rientation was unchanged, the observed reduction in the
roportion of thin, green fibers within the scars and the
ncrease in retardation are consistent with M-CSF–
nhancing healing. For example, increased fiber thickness
as been associated with increased scar stiffness (18) and
ncreased retardation with increased scar maturation (8,18).
The mechanism for this M-CSF–mediated enhancement
s presumably via enhanced macrophage infiltration (Fig.
D). Macrophage colony-stimulating factor is a lineage-
pecific cytokine that promotes the survival, proliferation,
nd differentiation of mononuclear phagocytes (19). Mono-
rdation differences. Higher retardation is denoted by a progression in pixel
(C) MI  G-CSF. Interstitial space has zero retardation—purple. The
than the MI control or G-CSF cases, consistent with enhanced healing.
ction Study (45-Min Occlusion Protocol)
MI
 11)
MI  M-CSF
(n  10)
MI  G-CSF
(n  12)
 0.012* 0.224  0.015* 0.222  0.011*
 12 401  10 411  8
 6.5 75.8  4.5 75.9  3.5
 1.0 3.1  0.8 3.5  0.7
 0.017* 0.116  0.012 0.135  0.011*
 0.042* 0.299  0.032 0.348  0.030*
 0.014* 0.199  0.012 0.213  0.010*
 0.037* 0.505  0.032 0.556  0.026*
 3.6 42.2  3.6 37.2  4.6
 2.3 33.1  3.0 32.4  3.8
 379 4736  414 4467  241
 87* 1650  146# 1292  128*
 0.9* 9.7  0.7 10.1  0.5
 0.012 0.067  0.010 0.066  0.016
heart rate; LVdP/dt max  maximum of the first derivative
LV end-diastolic volume; LVEF  LV ejection fraction;
olume;   time constant of LV pressure isovolumic decay;l reta
SF,
aluesr Fun
(n
.219
407
84.0
4.8
.146
.362
.225
.535
36.4
31.8
4493
1191
11.9
.071
MI.
HR 
DV 
tolic vme relationship); Vp  parallel conductance volume; other
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anced expression of MCP-1 in endothelial cells (20).
acrophages in the infarcted myocardium express c-Fms,
n M-CSF receptor (21), and are responsible not only for
emoval of necrotic myocytes, but also for promoting
brosis by secreting TGF-1 (22,23). Significantly higher
evels of TGF--1 and collagen mRNAs in infarcted
egions of M-CSF–treated MI hearts versus those in un-
reated MI hearts suggest enhanced production of TGF-
-1 and collagen in these regions (Fig. 3). Nonetheless, we
annot exclude the possibility that M-CSF also affected
ollagen degradation.
At the time we assessed LV function (14 days after MI),
brosis of control infarcted regions was incomplete. Thus, it
s possible that the impact of infarct repair acceleration by
-CSF on LV remodeling and function would be less
pparent if assessed later. Nevertheless, accelerated healing
ould reduce the time when the infarct is vulnerable to
igure 7. Relationships between left ventricular end-systolic elastance (Ees)
ith infarct collagen content (data pooled for all groups; [A] y  20.82x 
B] y  22.3x  3,167.5, r  0.36, p  0.05). Abbreviations as in F
able 3. Summary of Results From Ventricular Function Study
90-Min Occlusion Protocol)
Group
Sham
(n  5)
MI
(n  6)
MI  M-CSF
(n  6)
p (ml) 0.189  0.013 0.229  0.014 0.219  0.013
R (beats/min) 399  10 370  7 396  16
VESP (mm Hg) 84.3  6.2 71.1  7.7 70.3  4.4
VEDP (mm Hg) 2.9  1.1 3.4  1.9 1.7  0.5
VESV (mL) 0.094  0.007 0.165  0.019* 0.159  0.012*
VESV/BW (l/g) 0.236  0.011 0.408  0.042* 0.391  0.030*
VEDV (ml) 0.172  0.005 0.237  0.018* 0.215  0.014
VEDV/BW (l/g) 0.441  0.017 0.588  0.037* 0.523  0.029
VEF (%) 45.7  3.1 31.3  4.2* 25.8  4.1*
ardiac output
(ml/min)
31.6  3.5 26.9  3.4 22.2  3.9
VdP/dt max
(mm Hg/s)
5417  478 3322  397* 3421  321*
es (mm Hg/ml) 1775  193 956  77* 1353  123*#
(ms) 9.5  0.4 13.5  2.1 11.3  0.7
0 (ml) 0.044  0.007 0.090  0.017* 0.104  0.016*
nfarct size/LV (%) 37.6  2.5 39.8  1.6m
alues are means  SE. *p  0.05 vs. sham. #p  0.05 vs. MI.
Abbreviations as in Tables 1 and 2.echanically mediated expansion. Another potential con-
ounding factor is that the effects of M-CSF found in the
oung rats that we used may not necessarily be expected in
lder subjects in which the function of bone marrow and
irculating progenitor cells are reduced.
ffects of G-CSF on ventricular function and infarct
epair after MI. The effect of G-CSF on infarcted hearts is
ontroversial. Although initial studies using mice and rab-
its (1,4) suggested that G-CSF augmented myocyte regen-
ration in infarcted hearts by recruiting bone marrow-
erived stem cells, this finding was not confirmed in
ubsequent studies using primates, mice, and rats (2,3,5,24).
n these negative studies, using non-reperfused MI, im-
rovement in LV function after MI, which was associated
ith increased angiogenesis or collagen deposition in in-
arcted regions, was reported for mice (2) and rats (3,5) but
ot for primates (24). In our study, G-CSF neither induced
ubstantial myocyte regeneration nor improved LV function
n a rat model of reperfused MI. Although our method for
etecting myocyte regeneration may have underestimated its
ontribution, it is unlikely that the amount of such cardiac
egeneration, if any, was consequential, because neither
nfarct size nor infarct transmurality was reduced by
-CSF. These conflicting reports (1–5,24) cannot be
eadily reconciled; however, differences in protocols for
-CSF treatment, infarct size, severity of heart failure, and
nimal species might be responsible. In addition, the pres-
nce or absence of reperfusion may play a role because
eperfusion results in profound differences in the timing
min vs. h) and location (generally throughout the infarct vs.
order zones alone) of infiltration of circulating cells.
ummary. A close relationship between Ees and infarct
ransmurality confirmed the importance of myocardial sal-
age by reperfusion in preservation of ventricular function
fter myocardial infarction. These data extend and refine, in
more relevant clinical model, our earlier finding (5) that
ombined M/G-CSF therapy promoted healing and in vitro
V function after permanent coronary occlusion. Further-
gen content in infarct region, and infarct transmurality. The Ees correlated
7, r  0.42, p  0.05) and negatively correlated with infarct transmurality
1., colla
284.8ore, our current study indicated that favorable modulation
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chieved by M-CSF treatment alone.
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